FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
02/10/2022
Voltar para busca
Dado oficial do USPTO
MGISP
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
39
Atualização mais recente
02/10/2022
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5, 9, 10
Data de depósito
22/12/2020
Data de registro
24/05/2022
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
24/05/2022
Última transação
24/05/2022
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
99
Localização do titular
518083 Guangdong, CN
Examinador
LAM, HAI-LY HUYNH
Unidade examinadora
N10
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
MGI TECH CO., LTD.
Representantes
Charles Ho BYIP LTD.
Classificação técnica
Classes Nice
Classe 5Classe 9Classe 10
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Reagents for use in medical genetic testing; Reagents for gene detection for medical purposes; Medical diagnostic reagents; Medical diagnostic reagents for the analysis of immune system; Chemical reagents for medical or veterinary purposes; Pharmaceutical preparations for treating cancer and genetic diseases; Reagents for gene detection for veterinary purposes; Diagnostic biomarker reagents for medical purposes; Biological preparations for medical purposesfor treating cancer and genetic diseases; Dietetic substancesdietetic confectionery all adapted for medical use
Classe 9
Nucleic acid sequencers used for analyzing nucleic acids in scientific research; Surveying machines and instruments; Apparatus and measuring instruments for physical and chemical test and composition analysiselectronic analyzers for testing and analyzing chemical and biological substances for the presenceabsencequantity of target chemicalsbiologics and contaminants; Diagnostic apparatusnot for medical purposesfor the detection of pathogens for laboratory or research use; Laboratory equipmentprotein sequence analysis apparatus; Data processing apparatus; Laboratory apparatus and instrumentsgene analyzers for genome information; Gene amplification instrument for scientific research purposes; DNA microarrays for laboratory use; Computer programs being downloadable software for biological data mining; Computer programs being downloadable software for developing bioinformatics database for others; Computer programs being downloadable software for analyzing genome information
Classe 10
Medical apparatus for detecting geneflow cytometers and flow-based analyzers providing cell and particle analysis and detection for medical use; Apparatus for DNA and RNA testing for medical purposes; Apparatus for use in medical analysiscomputerized medical recording and analysis apparatus for the diagnosis and analysis of cancergenetic diseases and microbial infectious diseases; Apparatus for the regeneration of stem cells for medical purposes; Blood testing apparatus; Diagnostic apparatus for medical purposesdiagnostic apparatus for testing blood sugar levelscancer cells and DNA; Medical apparatus and instrumentsapparatus for medical diagnostic testing in the fields of cancer or other tissue-based diagnostic testingcytology and cell-based testing; Medical apparatus and instrumentsapparatus for detecting tumor cancer and genetic diseases; Medical apparatus and instrumentsapparatus for detecting and treating tumor and cancer; Apparatus for nursing infantsbaby nursersnursing bottles; Radiological apparatus for medical purposes
Publicações
Histórico de despachos e eventos da marca no USPTO.
39 publicações encontradas
FICS
FINAL DISPOSITION NOTICE SENT TO IB
10/09/2022
FIMP
FINAL DISPOSITION PROCESSED
09/09/2022
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
24/08/2022
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
24/05/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
24/05/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
15/04/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
15/04/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
15/04/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/03/2022
PUBO
PUBLISHED FOR OPPOSITION
01/03/2022
GPNX
NOTIFICATION PROCESSED BY IB
28/02/2022
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
09/02/2022
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
09/02/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/02/2022
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
25/01/2022
ALIE
ASSIGNED TO LIE
25/01/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
25/01/2022
XAEC
EXAMINER'S AMENDMENT ENTERED
10/01/2022
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
10/01/2022
GNEA
EXAMINERS AMENDMENT E-MAILED
10/01/2022
CNEA
EXAMINERS AMENDMENT -WRITTEN
10/01/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
28/12/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
28/12/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
28/12/2021
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
16/08/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
16/08/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
16/08/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
16/08/2021
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
16/08/2021
RFNT
REFUSAL PROCESSED BY IB
19/07/2021
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
30/06/2021
RFRR
REFUSAL PROCESSED BY MPU
30/06/2021
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
24/06/2021
CNRT
NON-FINAL ACTION WRITTEN
23/06/2021
DOCK
ASSIGNED TO EXAMINER
18/06/2021
MAFR
APPLICATION FILING RECEIPT MAILED
09/04/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/04/2021
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
01/04/2021
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace MGISP ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.